|
Gaucher Disease Research Highlights: ASH 2020
At the American Society of Hematology Annual Meeting (ASH 2020), new information and data were presented on Gaucher disease, a rare lysosomal storage disorder, that requires a team of health care professionals to properly manage. This CME activity highlights the latest information about Gaucher disease from ASH 2020 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition.
Activity Faculty
|
|
Meeting the Challenges in Management of Sickle Cell Disease
No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outc... |
|
Update on Therapeutic Advances in T-Cell Lymphoma
Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity!
STATEMENT OF NEED
Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people die of the disease (ACS, 2020). Among these cases, 12% to 15% are classified as peripheral T-cell l... |
|
|
Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients
STATEMENT OF NEED
Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruritus, atopic dermatitis is associated with a substantial and multifaceted patient-reported burden tha... |
|
Expert Updates in COVID19: An Animated Video Series
Five animated videos clearly explain managing patients with COVID19, lung disease, ARDS, or long-COVID. Hear from the leading pulmonologists on best practices based on the latest literature. |
|
|
Assessing a Patient With Long COVID-19: An Interactive Case Scenario
In this interactive case, the physician recommends a series of assessments for your patient with Long-COVID symptoms. For each assessment, the user chooses the outcome to hear recommendations from the experts. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
|
Eye on Neuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently. |
|
|
Pulmonary Arterial Hypertension (PAH) Highlights from CHEST 2020
Although CHEST 2020 was not a live, in-person meeting, new information and data regarding pulmonary arterial hypertension (PAH) will still be published but will not be easily accessible to the care team involved in the diagnosis and management of patients with this rare disease who need to know and incorporate the latest information into patient care. This CME activity highlights the latest research on PAH to help clinicians keep up to date on the most efficient ways to manage their patients. |
|
Advanced Basal Cell Carcinoma: How to Navigate Challenging Clinical Scenarios With Systemic Treatment
Join Karl Lewis, MD, and Aleksandar Sekulic, MD, PhD, as they discuss the importance of the hedgehog pathway in the pathogenesis of BCC and the role of hedgehog inhibitors in advanced BCC. Evidence related to the safety and efficacy of the approved hedgehog inhibitors sonidegib and vismodegib are discussed, with recommendations for optimizing their use. Case studies are utilized to share the faculty’s experience in treating patients with hedgehog inhibitors, including strategies to manage re... |
|
|
Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies)
STATEMENT OF NEED
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents during the first year following HSCT but may develop in subsequent years and most commonly affects the ... |
|
Optimal Prehospital Management of Seizure Emergencies
In this program, the faculty will review and provide updates on the guidelines for managing seizure emergencies and address how participants can reduce the barriers to prehospital treatment through the use of Seizure Action Plans. They also will discuss recent clinical trials that may improve caregiver acceptance of rescue medications for status epilepticus. In addition, the faculty will address the similarities and differences in managing seizure emergencies for pediatric and adult patients. |
|
Research Updates in Gout: Improving Response Rate to Therapy
Dr. Brian Mandell and Dr. Naomi Schlesinger discuss recent published evidence related to gout, as well as study results presented at the American College of Rheumatology Convergence 2020 virtual annual meeting. Dr. Schlesinger begins with an introduction on a recent published systematic review indicating that the manifestations of gout extend beyond the joints, affecting other organs and tissues. Dr. Schlesinger also provides an overview of some of the challenges encountered in clinical practi... |
|
A Case-Based Roadmap for Improved Patient Outcomes in Psoriatic Arthritis
Patients with psoriatic arthritis (PsA) experience significant disease burden due to incomplete diagnostic evaluation and suboptimal use of effective therapies. In this case-based activity, Dr. Leonard Calabrese of the Cleveland Clinic addressing these practice gaps by sharing his recommendations for patient management at critical decision points in the diagnosis and treatment of patients with PsA. Dr. Calabrese also discusses the important role of shared decision-making over the course of the... |
|
Immunotherapy Advances in RRMM: An Educational Journey
Multiple myeloma has become the most common hematologic malignancy in the United States adult population with over 120,000 people living with the disease. Despite new and more effective treatments, multiple myeloma, unfortunately, remains largely incurable with relapse and disease progression still common.
Dr. Ola Landgren Chief of the Myeloma Service at Memorial Sloan-Kettering Cancer Center and professor of medicine at Cornell Medical College discusses advances in the field of immunothera... |
|
Meeting the Medical Needs of Patients with Ulcerative Colitis During the COVID-19 Pandemic
The COVID-19 pandemic is an unprecedented challenge for all healthcare systems worldwide. Gastroenterologists and clinicians who actively manage patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC), need to ensure they are taking steps to minimize the risk of infection for their patients.
Russell D. Cohen, MD, shares his expert perspective as an author of the recently published AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the C... |
|
Eosinophilia in Patients With Asthma: A Sign of Eosinophilic Granulomatosis With Polyangiitis (EGPA)
PART 1: Welcome to this overview of eosinophilic granulomatosis with polyangiitis with Michael Wechsler, MD. In this activity, Dr. Wechsler reviews the pathogenesis, diagnosis, prognosis, and treatment of EGPA. This presentation will help you recognize EGPA and differentiate it from other diagnoses and other small-vessel vasculitides, and develop treatment plans based on the patient’s prognosis and response to first-line treatments.
PART 2: Welcome to this video question and answer inte... |
|
|
Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma
STATEMENT OF NEED
Merkel cell carcinoma is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 2,488 cases are diagnosed in the United States annually (Paulson et al, 2018). The incidence of MCC has risen rapidly during the past few decades, which has been attributed in part to people living longer with increased sun exposure and weakened immune systems, a feature that suggests an infectious origin an... |
|
|
New Data and Clinical Perspectives on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States. An estimated 191,930 new cases are diagnosed annually, and 33,330 people die from the disease (ACS, 2020). Most patients with metastatic hormone-sensitive prostate cancer (HSPC) present with relapse after local treatment, while approximately 5% of all prostate cancer patients present with de novo metastatic HSPC (Ng et al, 2020). The five-year overall survival rate for metastatic HSPC remains... |
|
|
Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders
ACTIVITY OVERVIEW
Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications a... |
|
|
Expert Guidance on New Advances in Renal Cell Carcinoma
STATEMENT OF NEED
Kidney cancer accounts for approximately 4% of all cancer diagnoses in the United States (ACS, 2020). An estimated 73,750 new cases are reported annually and 14,830 people die of the disease. Renal cell carcinoma, which comprises nearly 90% of all kidney cancers, is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. Due to its often asymptomatic presentation, many patients have advanced disease at ... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer
STATEMENT OF NEED
Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2020). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement eventually develop metastatic disease (Siegel et al, 2020; Mortensen et al, 2018). Women with metastat... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma
STATEMENT OF NEED
Of the estimated 74,200 new cases of non-Hodgkin lymphoma each year in the United States, approximately 22% are FL, an indolent, difficult-to-treat B-cell malignancy (ACS, 2019; NCCN, 2019). Most patients are diagnosed at an average age of 63 years (NCI, 2019). Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrence... |
|
|
Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma
STATEMENT OF NEED
Soft tissue sarcomas are a heterogeneous group of malignancies that arise primarily from the mesodermal tissues of the extremities, trunk and retroperitoneum, and head and neck. An estimated 13,130 new cases are diagnosed in the United States annually and 5,350 people die of the disease. Surgical resection is the mainstay of treatment for localized soft tissue sarcoma, with radiation and chemotherapy commonly used as adjuncts. However, nearly 50% of patients will experienc... |
|
|
Navigating the Recent Rheumatoid Arthritis Guidelines to Achieve Disease Remission and Reduce Patient
Roy M. Fleischmann, MD, discusses the latest evidence for the management of patients with moderate-to-severe rheumatoid arthritis who do not achieve treatment goals with initial disease-modifying anti-rheumatic drug therapy. A key treatment principle emphasized by Dr. Fleischmann is using a treat-to-target approach guided by validated tools for assessing disease activity and patient-reported outcomes. Among the treatment options, Dr. Fleischmann highlights the pharmacology of the latest approv... |
|
Navigating Advancements in Diagnosis & Treatment of Axial Spondyloarthritis
More than 80% of the population has significant back pain at some point in their life, with 30% of adults in the United States stating they have chronic low back pain at any given time; 5% of whom have inflammatory back pain. Axial spondyloarthritis (axSpA) affects almost 1.5% of patients with inflammatory back pain; however, the majority of individuals suffering with back pain are not being treated by a rheumatologist, which only exacerbates the challenge to diagnose those with axSpA.
Dr.... |
|
Research Developments in Atopic Dermatitis
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial re... |
|
|
Defining Personalized Care Plans in Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer (CRC) is the third leading cause of cancer death among men and women in the United States. An estimated 145,600 new cases are diagnosed annually and 51,020 people die of the disease. When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because CRC initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages. Approximately 21% of patients present with m... |
|
|
Tumor-induced Osteomalacia (TIO): Diagnosis and Management
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic condition commonly characterized by bone pain, muscle weakness and fractures. These tumors secrete excess fibroblast growth factor 23 (FGF23) which inhibits the sodium phosphate renal co-transporters and suppresses 1α hydroxylase activity, thereby decreasing renal reabsorption and increased urinary phosphate excretion. As a result, unexplainable hypophosphatemia with a variety of musculoskeletal abnormalities are the most common sympto... |
|
|
Neuroendocrine Tumors (NETs) Research Highlights from ENDO 2020
Although the 2020 Endocrine Society’s annual meeting (ENDO 2020) did not take place as scheduled, abstracts, including new information and data on neuroendocrine tumors (NETs) were published. This CME activity highlights the latest information about NETs from ENDO 2020 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with these rare diseases. |
|
|
Exploring Novel Treatment Strategies for Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer (CRC) is the third leading cause of cancer death among men and women in the United States. An estimated 145,600 new cases are diagnosed annually and 51,020 people die of the disease. When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because CRC initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages. Approximately 21% of patients present with m... |
|
|
Clinical Updates and Expert Guidance in Prostate Cancer
STATEMENT OF NEED
Prostate cancer is the most common tumor type affecting men in the United States, with an estimated 174,650 new cases reported each year. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significa... |
|
|
Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes
STATEMENT OF NEED
Myelodysplastic syndromes (MDS) are a group of heterogeneous hematopoietic disorders derived from an abnormal multipotent progenitor cell, characterized by ineffective hematopoiesis, bone marrow failure, and peripheral blood cytopenias. Survival in MDS ranges from a median of 5.3 years in lower-risk patients to as little as 0.8 years in higher-risk patients. Mortality is usually a result of infection, hemorrhage, and/or iron overload secondary to red blood cell transfusion... |
|
|
@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice
Statement of Need
Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation - it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients ... |
|
|
Food Allergy: From Primary Prevention to Treatment and Intervention Online
This online offering includes 19 videos of lectures and panel discussions on the diagnosis and management, specific syndromes, treatment, and research and prevention of food allergy. The videos were recorded at a live course that took place at a live AAAAI course held in early September, 2019.
The intent of the videos is to allow learners to increase their knowledge related to the diagnosis and management of food allergic patients. It highlights the latest evidence related to food allergie... |
|
|
Conversations from the World of Allergy: Podcast Episodes for Credit
This podcast features interviews on a wide variety of allergy/immunology topics. It is our hope that the conversations provide evidence-based information that is useful to clinicians, researchers and patients, alike.
Some episodes are available for CME credit. All podcast episodes are available at https://www.aaaai.org/professional-education-and-training/podcasts |
|
|
Virtual Patient: Asthma in the Older Adult
This patient simulation requires an evaluation and creation of a treatment plan for an older adult (>65 years old) with asthma. The case involves identification of differences and similarities between asthma and COPD in older adults and consideration of medications and co-morbid conditions that may complicate the management of asthma in this population. A summary of the literature supporting best practices in asthma care in the older adult will be provided. |
|
|
2021 Advances in Rheumatology: Implementing Best Practices into Clinical Care Enduring Material Module 2: Telerheumatology: Update Post-Covid
Target Audience
This activity is designed to meet the educational needs of Rheumatology Fellows, Rheumatologists and other healthcare providers involved in the clinical care of patients with rheumatic diseases.
Statement of Need/Program Overview
The four modules in this activity are designed to provide the participant with a better understanding regarding the most commonly used Patient Reported Outcomes (PRO), the composition of the different commonly used disease activity measures (DAM) ... |
|
|
AL Amyloidosis: Identifying Patients, Implementing Care
Light chain (AL) amyloidosis, a rare clonal plasma cell disorder characterized by organ deposition of amyloid protein, results in progressive organ damage that is usually irreversible. Prompt treatment is critical to achieving the best possible outcomes, but rapid initiation of treatment requires early, accurate diagnosis, which is often delayed because of the nonspecific nature of the symptoms. Unfortunately, delayed diagnosis is a grave concern, as the median survival rate among some untreat... |
|
|
Applying Risk-Adapted Approaches to Management of MDS
Target Audience
The intended audience for this activity are hematologic oncologists, hematologists, medical oncologists, BMT specialists, oncology advanced practice providers (NPs and PAs), oncology nurses, and other clinicians involved in the management of patients with MDS.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Review validated MDS classification systems and risk-stratification models
Discuss the treatment algorithm for low-risk... |
|
|
Patient, Provider & Caregiver Connection™: Improving Outcomes for Your Patient with Atopic Dermatitis
Target Audience
This online educational activity is directed toward dermatologists, primary care physicians, nurse practitioners, physician assistants, and additional members of the multidisciplinary care team.
Program Overview
This video-based program is designed to help healthcare professionals explore the management and treatment of atopic dermatitis (AD) through a unique perspective, putting the patient voice front and center. A patient and caregiver will lend their expertise to this ... |
|
|
Initiating Medication-Assisted Therapy for OUD in Diverse Settings: Clinical Pearls for Navigating the Process
The opioid abuse epidemic has resulted in an alarming increase in opioid-related overdoses and deaths; however, the severe and lethal consequences of opioid misuse is preventable with the use of medication-assisted treatment (MAT), which is a proven, effective tool for patients with opioid use disorder (OUD).
Research has demonstrated that MAT is effective in reducing opioid use and overdoses, increasing treatment retention, diminishing risky behaviors that contribute to the transmission of... |
|
|
ECG in Primary Care
ALL AMS CME 2021 medical conferences are Live, half-day, Commercial Support Free medical events and are approved for AMA PRA Category 1 Credits™. Additional accreditation can be found on our website.
All of our medical meetings are clinically useful evidence/case-based, guideline-driven, Primary Care content that is immediately applicable to your practice. All of our CME conferences, both live and recorded, can be found at www.AmericanMedicalSeminars.com.
AMS CME meetings are held in... |
|
|
Managing Advanced Prostate Cancer in the COVID-19 Era: What Do Oncologists Need to Know?
Learning Objectives
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine. At the conclusion of this education, participants should be able to:
This program is designed to address ACPE competencies, including foundational knowledge, essentials for practice and care, and approaches to practice and care.
Evaluate current and emerging treatments for patients with advanced prostate cance... |
|
|
Optimizing Care of Cervical Dystonia: Improving Diagnosis and Skills for Localization and Injection of Affected Muscles with Botulinum Neurotoxin
Target Audience
This activity has been designed for neurologists and physiatrists. It may also benefit other healthcare providers—including internists and family physicians—who often work in concert with neurologists and physiatrists and/or are interested and actively engaged in the management of patients with cervical dystonia.
Statement of Need/Program Overview
Evidence suggests that cervical dystonia is underdiagnosed and undertreated, and that when treatment with botulinum neu... |
|
|
Grand Arabian Gulf Cruise: Exploring Medicine, Dentistry & the Middle Eastern Healthcare Model
Pyramids, Petra & Glittering Skylines! Join PES for 17 nights to discover thousands of years of history and extravagant modern marvels with overnights in Luxor, Petra, Dubai, and Abu Dhabi offering more time for exploration, while sailing aboard the all-inclusive and award-winning Crystal Symphony! Hosted by Joann & Bill Chaney!
Exploring Medicine, Dentistry & the Middle Eastern Healthcare Model
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
Thi... |
|
|
Eastern Seaboard Cruise: Joint Medical/Dental Symposium Confronting Healthcare Needs
Fall in New England & Southern Charm! Join PES for 14 nights on a close-to-home east coast getaway with overnights in Québec City, Boston, New York City, and Charleston offering more time for exploration, while sailing aboard the all-inclusive and award-winning Crystal Serenity!
Joint Medical/Dental Symposium Confronting Healthcare Needs
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This Seminar is planned for 14 Continuing Education Credit Ho... |
|
|
Captivating Caribbean Cruise: Symposia on Hospital, Palliative, Primary & Dental Care
Close-to-Home Getaway, Roundtrip Miami! Join PES and cruise the idyllic isles of the Eastern Caribbean for 12 nights in all-inclusive luxury. Rejuvenate and indulge while exploring the white sands and crystalline waters of a tropical paradise, sailing aboard the award-winning Crystal Serenity! Hosted by Dr. Thomas & Dr. Gabriella Miller!
Symposia on Hospital, Palliative, Primary & Dental Care
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This S... |
|
|
Primary Care: Internal Medicine Conference
We get it. Some people are ready to travel and some people are not. The choice should be yours. At CME Seminars, all of our seminars are both live events and streamed as a webinar. You have your choice to attend using either option. We offer that same choice to our speakers. If a speaker attends remotely, the session will still be live and in real time. When you sign up for a seminar, you can choose the other option if you change your mind and receive a no hassle refund or upcharge for th... |
|
|
Primary Care: Pediatric Emergency Medicine Update
We get it. Some people are ready to travel and some people are not. The choice should be yours. At CME Seminars, all of our seminars are both live events and streamed as a webinar. You have your choice to attend using either option. We offer that same choice to our speakers. If a speaker attends remotely, the session will still be live and in real time. When you sign up for a seminar, you can choose the other option if you change your mind and receive a no hassle refund or upcharge for th... |
|